Developing new treatments to combat bacterial resistance using biopharmaceuticals
Preclinical Services for Antibacterial Resistance Biopharmaceutical Product Development
['FUNDING_OTHER'] · UNIVERSITY OF SASKATCHEWAN · NIH-10934790
This study is working on new treatments to help fight stubborn bacterial infections that don't respond to regular antibiotics, so patients can have better options for getting better.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF SASKATCHEWAN (nih funded) |
| Locations | 1 site (SASKATOON, CANADA) |
| Trial ID | NIH-10934790 on ClinicalTrials.gov |
What this research studies
This research focuses on the preclinical development of innovative biopharmaceutical products aimed at addressing bacterial drug resistance. It involves creating and evaluating various biological materials, including small interfering RNA (siRNA) and monoclonal antibodies, to enhance treatment options for infectious diseases. The approach includes product development planning, assay development, and regulatory support to ensure effective translation of these therapies into clinical settings. Patients may benefit from new therapies that could be more effective against resistant bacterial infections.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals suffering from infections caused by antibiotic-resistant bacteria.
Not a fit: Patients with infections that are not caused by bacterial pathogens or those who do not have antibiotic-resistant infections may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of new treatments that effectively combat bacterial infections resistant to current therapies.
How similar studies have performed: Previous research has shown promise in developing biopharmaceuticals for infectious diseases, indicating that this approach has potential for success.
Where this research is happening
SASKATOON, CANADA
- UNIVERSITY OF SASKATCHEWAN — SASKATOON, CANADA (ACTIVE)
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Infectious Diseases Research, Infectious Diseases / Laboratory